13F Data
13F filer · CIK 1766721

Aisling Capital Management LP

NEW YORK, NY · filing since Q4 2018 · last filing Aug 13, 2026
Reported value
$471.6M
$-4.7M vs prior
Positions
14
New / sold out
1 / 0
Added / reduced
0 / 1
Turnover
0.4%
buys $1.9M · sells $37.2M
Top-10 weight
99.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewVTV THERAPEUTICS INC+50,000–+$1.9M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedBRIDGEBIO PHARMA INC-500,000-9.8%$-37.2M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2018: $94.9MQ1 2019: $131.3MQ2 2019: $234.1MQ3 2019: $191.8MQ4 2019: $261.0MQ1 2020: $229.6MQ2 2020: $262.0MQ3 2020: $313.0MQ4 2020: $582.3MQ1 2021: $555.6MQ2 2021: $624.6MQ3 2021: $501.5MQ4 2021: $283.5MQ1 2022: $185.3MQ2 2022: $140.2MQ3 2022: $150.6MQ4 2022: $151.5MQ1 2023: $207.8MQ2 2023: $204.1MQ3 2023: $242.7MQ4 2023: $335.2MQ1 2024: $295.5MQ2 2024: $231.1MQ3 2024: $261.1MQ4 2024: $281.8MQ1 2025: $288.5MQ2 2025: $359.7MQ3 2025: $456.4MQ4 2025: $478.9MQ1 2026: $476.3MQ2 2026: $471.6M
Q4 2018Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1BRIDGEBIO PHARMA INCCOM4,589,611$341.8M72.48%
2MONTE ROSA THERAPEUTICS INCCOM1,555,664$37.6M7.98%
3SYNDAX PHARMACEUTICALS INCCOM1,316,806$28.8M6.10%
4COMPASS PATHWAYS PLCSPONSORED ADS1,432,336$20.3M4.30%
5BICARA THERAPEUTICS INCCOM568,919$16.9M3.58%
6BRIDGEBIO ONCOLOGY THERAPEUTCOM NEW1,018,018$7.8M1.64%
7SCHOLAR ROCK HLDG CORPCOM77,031$4.2M0.90%
8UROGEN PHARMA LTDCOM108,000$4.0M0.84%
9BIOMEA FUSION INCCOM2,048,757$3.0M0.64%
10ACLARIS THERAPEUTICS INCCOM434,455$2.3M0.49%
4 more rows. Subscribe for $29/month to see every row, download the data and use the API.